The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123433683 12343368 3 F 201604 20160715 20160506 20160726 EXP CA-ALEXION PHARMACEUTICALS INC.-A201603186 ALEXION 36.33 YR F Y 85.00000 KG 20160726 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123433683 12343368 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
123433683 12343368 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
123433683 12343368 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
123433683 12343368 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 1200 MG, SINGLE 125166 1200 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
123433683 12343368 5 C WARFARIN WARFARIN 1 Unknown 0
123433683 12343368 6 C HEPARIN HEPARIN SODIUM 1 Intravenous (not otherwise specified) 0
123433683 12343368 7 C PREDNISONE. PREDNISONE 1 Unknown 75 MG, QD 0 75 MG QD
123433683 12343368 8 C RITUXIMAB RITUXIMAB 1 Unknown UNK 0
123433683 12343368 9 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown UNK 0
123433683 12343368 10 C AZATHIOPRINE. AZATHIOPRINE 1 Unknown UNK 0
123433683 12343368 11 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Unknown 0
123433683 12343368 12 C VORICONAZOLE. VORICONAZOLE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123433683 12343368 1 Antiphospholipid syndrome
123433683 12343368 5 Anticoagulant therapy
123433683 12343368 6 Anticoagulant therapy
123433683 12343368 7 Product used for unknown indication
123433683 12343368 8 Immunosuppression
123433683 12343368 9 Immunosuppression
123433683 12343368 10 Immunosuppression
123433683 12343368 11 Cardiac failure
123433683 12343368 12 Antiphospholipid syndrome

Outcome of event

Event ID CASEID OUTC COD
123433683 12343368 HO
123433683 12343368 OT
123433683 12343368 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
123433683 12343368 Bacteraemia
123433683 12343368 Cerebrovascular accident
123433683 12343368 Cytomegalovirus viraemia
123433683 12343368 Haemodynamic instability
123433683 12343368 Haemolysis
123433683 12343368 Hepatic failure
123433683 12343368 Hypotension
123433683 12343368 Meningitis viral
123433683 12343368 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123433683 12343368 1 20160326 20160326 0
123433683 12343368 2 20160401 20160401 0
123433683 12343368 3 20160408 20160408 0
123433683 12343368 4 20160415 20160415 0
123433683 12343368 8 201510 0
123433683 12343368 9 201602 0
123433683 12343368 10 201511 201602 0